Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Prostate Cancer

  Free Subscription


28.06.2021

1 Am J Clin Pathol
3 BJU Int
2 Br J Cancer
1 Cancer
1 Cancer Lett
2 Cancer Res
1 Clin Cancer Res
1 Clin Imaging
1 Eur Radiol
4 Eur Urol
1 Int J Cancer
3 Int J Urol
1 J Surg Oncol
1 J Urol
1 Lancet Oncol
1 Magn Reson Imaging
1 N Engl J Med
1 Nat Rev Urol
1 Oncogene
1 Oncol Rep
2 PLoS One
1 Pol J Radiol
2 Prog Urol
1 Prostate
1 Urol Int
2 Urology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Pathol

  1. MANKUZHY NP, Almahariq MF, Ye H, Amin M, et al
    Investigation of the Prognostic Significance of Neuroendocrine Differentiation in Gleason Score 7 to 10 Prostate Adenocarcinoma in Patients With Distant Metastasis After Definitive Radiotherapy.
    Am J Clin Pathol. 2021;155:879-886.
    PubMed         Abstract available


    BJU Int

  2. DIRIE J, Mahesan T, Hart E, Janardanan S, et al
    Delivering safe and timely cancer care during COVID-19: lessons and successes from the transition period.
    BJU Int. 2021;127:633-635.
    PubMed        

  3. TANDOGDU Z, Collins J, Shaw G, Rohn J, et al
    Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statement.
    BJU Int. 2021;127:729-741.
    PubMed         Abstract available

  4. BERTONCELLI TANAKA M, Sahota K, Burn J, Falconer A, et al
    Prostate cancer in transgender women: what does a urologist need to know?
    BJU Int. 2021 Jun 22. doi: 10.1111/bju.15521.
    PubMed         Abstract available


    Br J Cancer

  5. SJOBERG HT, Philippou Y, Magnussen AL, Tullis IDC, et al
    Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer.
    Br J Cancer. 2021 Jun 21. pii: 10.1038/s41416-021-01450.
    PubMed         Abstract available

  6. LAN T, Park Y, Colditz GA, Liu J, et al
    Adolescent animal product intake in relation to later prostate cancer risk and mortality in the NIH-AARP Diet and Health Study.
    Br J Cancer. 2021 Jun 16. pii: 10.1038/s41416-021-01463.
    PubMed         Abstract available


    Cancer

  7. QUINN TP, Sanda MG, Howard DH, Patil D, et al
    Disparities in magnetic resonance imaging of the prostate for traditionally underserved patients with prostate cancer.
    Cancer. 2021 Jun 17. doi: 10.1002/cncr.33518.
    PubMed         Abstract available


    Cancer Lett

  8. YAMADA Y, Beltran H
    The treatment landscape of metastatic prostate cancer.
    Cancer Lett. 2021 Jun 18. pii: S0304-3835(21)00295.
    PubMed         Abstract available


    Cancer Res

  9. HUANG Z, Tang B, Yang Y, Yang Z, et al
    MAP3K7-IKK inflammatory signaling modulates AR protein degradation and prostate cancer progression.
    Cancer Res. 2021 Jun 22. pii: 0008-5472.CAN-20-4194.
    PubMed         Abstract available

  10. SENA LA, Denmeade SR
    Fatty acid synthesis in prostate cancer: vulnerability or epiphenomenon?
    Cancer Res. 2021 Jun 18. pii: 0008-5472.CAN-21-1392.
    PubMed         Abstract available


    Clin Cancer Res

  11. KIM DH, Sun D, Storck WK, Welker Leng KR, et al
    BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program.
    Clin Cancer Res. 2021 Jun 18. pii: 1078-0432.CCR-20-4968.
    PubMed         Abstract available


    Clin Imaging

  12. MAGEE D, Perlis N, Corr K, Chan R, et al
    Salvage interstitial laser thermal therapy under MRI guidance (MRgFLA) for high-intensity focal ultrasound (HIFU) recurrences: feasibility study.
    Clin Imaging. 2021;76:217-221.
    PubMed         Abstract available


    Eur Radiol

  13. BURA V, Caglic I, Snoj Z, Sushentsev N, et al
    MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences.
    Eur Radiol. 2021;31:4908-4917.
    PubMed         Abstract available


    Eur Urol

  14. GHADJAR P, Hayoz S, Bernhard J, Zwahlen DR, et al
    Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial.
    Eur Urol. 2021 Jun 14. pii: S0302-2838(21)01802.
    PubMed         Abstract available

  15. WILKINSON S, Ye H, Lis RT, Sowalsky AG, et al
    Reply to Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, and Rodolfo Montironi's Letter to the Editor re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance
    Eur Urol. 2021 Jun 17. pii: S0302-2838(21)01808.
    PubMed        

  16. CIMADAMORE A, Cheng L, Lopez-Beltran A, Scarpelli M, et al
    Re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.009: Focus on Intraductal Carcinoma o
    Eur Urol. 2021 Jun 17. pii: S0302-2838(21)01807.
    PubMed        

  17. GLICKSMAN RM, Berlin A
    Reply to Wei Liu, Katherine Zukotynski, and Glenn Bauman's Letter to the Editor re: Rachel M. Glicksman, Ur Metser, Douglass Vines, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospect
    Eur Urol. 2021 Jun 19. pii: S0302-2838(21)01810.
    PubMed        


    Int J Cancer

  18. HEIDRICH I, Ackar L, Mossahebi Mohammadi P, Pantel K, et al
    Liquid biopsies: Potential and challenges.
    Int J Cancer. 2021;148:528-545.
    PubMed         Abstract available


    Int J Urol

  19. NAKAJIMA K, Mizokami A, Matsuyama H, Ichikawa T, et al
    Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study.
    Int J Urol. 2021 Jun 19. doi: 10.1111/iju.14614.
    PubMed         Abstract available

  20. KIMURA Y, Honda M, Teraoka S, Yumioka T, et al
    Impact of penile rehabilitation with phosphodiesterase-5 inhibitors on recovery of erectile function in patients undergoing robot-assisted radical prostatectomy: A propensity score-matched analysis.
    Int J Urol. 2021;28:637-642.
    PubMed         Abstract available

  21. TAGUCHI S, Morikawa T, Shibahara J, Fukuhara H, et al
    Prognostic significance of tertiary Gleason pattern in the contemporary era of Gleason grade grouping: A narrative review.
    Int J Urol. 2021;28:614-621.
    PubMed         Abstract available


    J Surg Oncol

  22. THOMSEN FB, Garmo H, Brasso K, Egevad L, et al
    Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study.
    J Surg Oncol. 2021 Jun 18. doi: 10.1002/jso.26579.
    PubMed         Abstract available


    J Urol

  23. TANEJA SS
    Urological Oncology: Prostate Cancer.
    J Urol. 2021 Jun 21:101097JU0000000000001921. doi: 10.1097/JU.0000000000001921.
    PubMed        


    Lancet Oncol

  24. THE LANCET ONCOLOGY
    Brachytherapy-a dose of pragmatism needed.
    Lancet Oncol. 2021;22:737.
    PubMed        


    Magn Reson Imaging

  25. ZHANG KS, Schelb P, Kohl S, Radtke JP, et al
    Improvement of PI-RADS-dependent prostate cancer classification by quantitative image assessment using radiomics or mean ADC.
    Magn Reson Imaging. 2021;82:9-17.
    PubMed         Abstract available


    N Engl J Med

  26. SARTOR O, de Bono J, Chi KN, Fizazi K, et al
    Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMoa2107322.
    PubMed         Abstract available


    Nat Rev Urol

  27. KIM JS, Galvao DA, Newton RU, Grey E, et al
    Exercise-induced myokines and their effect on prostate cancer.
    Nat Rev Urol. 2021 Jun 22. pii: 10.1038/s41585-021-00476.
    PubMed         Abstract available


    Oncogene

  28. HAGIWARA M, Fushimi A, Yamashita N, Bhattacharya A, et al
    MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells.
    Oncogene. 2021 Jun 23. pii: 10.1038/s41388-021-01899.
    PubMed         Abstract available


    Oncol Rep

  29. TORRES MJ, Lopez-Moncada F, Herrera D, Indo S, et al
    Endothelin-1 induces changes in the expression levels of steroidogenic enzymes and increases androgen receptor and testosterone production in the PC3 prostate cancer cell line.
    Oncol Rep. 2021;46.
    PubMed         Abstract available


    PLoS One

  30. PAROL-KULCZYK M, Gzil A, Maciejewska J, Bodnar M, et al
    Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study.
    PLoS One. 2021;16:e0253112.
    PubMed         Abstract available

  31. KIM SI, Szeto AH, Morgan KP, Brower B, et al
    A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.
    PLoS One. 2021;16:e0253021.
    PubMed         Abstract available


    Pol J Radiol

  32. KUS AA
    The utility of ADC parameters in the diagnosis of clinically significant prostate cancer by 3.0-Tesla diffusion-weighted magnetic resonance imaging.
    Pol J Radiol. 2021;86:e262-e268.
    PubMed         Abstract available


    Prog Urol

  33. DELEUZE C, Blanchet P, Gourtaud G, Senechal C, et al
    [High-intensity focused ultrasound for locally prostate cancer: An Afro-Caribbean single-center study].
    Prog Urol. 2021 Jun 18. pii: S1166-7087(21)00030.
    PubMed         Abstract available

  34. BISCANS C, Vallee M, Ingrand P, Debiais-Delpech C, et al
    Comparison between MRI and choline-PET trans-perineal target biopsies and saturation biopsies for detection and topography of intra-prostatic recurrence after primary radiation therapy for prostate cancer.
    Prog Urol. 2021 Jun 18. pii: S1166-7087(21)00116.
    PubMed         Abstract available


    Prostate

  35. LEE JM, Kim U, Yang H, Ryu B, et al
    TALEN-mediated generation of Nkx3.1 knockout rat model.
    Prostate. 2021;81:182-193.
    PubMed         Abstract available


    Urol Int

  36. FERRO M, Terracciano D, Musi G, de Cobelli O, et al
    Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies.
    Urol Int. 2021 Jun 24:1-8. doi: 10.1159/000516680.
    PubMed         Abstract available


    Urology

  37. SOERENSEN SJC, Thomas IC, Schmidt B, Daskivich T, et al
    Reply to the Editorial Comment on: Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration. Urology. 2021.
    Urology. 2021 Jun 14. pii: S0090-4295(21)00488.
    PubMed         Abstract available

  38. CAMPBELL RA, Li J, Malone L, Levy DA, et al
    Correlative Analysis of Vitamin D and Omega-3 Fatty Acid Intake in Men on Active Surveillance for Prostate Cancer.
    Urology. 2021 Jun 15. pii: S0090-4295(21)00525.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: